Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Adam O. Shea"'
Autor:
Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, Urs B. Hagemann
The clinical efficacy of the first approved alpha pharmaceutical, Xofigo (radium-223 dichloride, 223RaCl2), has stimulated significant interest in the development of new alpha-particle emitting drugs in oncology. Unlike radium-223 (223Ra), the parent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e35ca4b99143e9db09cefc4dfb3643
https://doi.org/10.1158/1535-7163.c.6537598.v1
https://doi.org/10.1158/1535-7163.c.6537598.v1
Autor:
Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, Urs B. Hagemann
Blood samples from animals treated with vehicle and CD33-TTC, administered at the different dose levels, were taken at Day -1, Day 67 and Day 123. (A) White blood cell counts, expressed in 109/L. (B) Red blood cell counts, expressed in 1012/L.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08e61add3f7aa0bbca94cc30520932a5
https://doi.org/10.1158/1535-7163.22504039.v1
https://doi.org/10.1158/1535-7163.22504039.v1
Autor:
Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, Urs B. Hagemann
Supplementary figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361388845c3296c2208652b4c5f1bd17
https://doi.org/10.1158/1535-7163.22504033
https://doi.org/10.1158/1535-7163.22504033
Autor:
Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, Urs B. Hagemann
Thorium-227 is purified from actinium-227 (227Ac). Thorium-227 decays via its alpha- and beta-emitting daughters to stable nonradioactive 207Pb. The energy emitted at each decay step (in MeV) are summarized. When thorium-227 decays to radium-223, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f22fb266f9a191731b0ff6f2d053ec
https://doi.org/10.1158/1535-7163.22504045
https://doi.org/10.1158/1535-7163.22504045
Autor:
Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, Urs B. Hagemann
Isolated kidneys (A, B) and bone marrow (C, D) were co-stained with a CD33-specific antibody (A, C) and a CD45-specific antibody (B, D).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208fb2fc7d4c3690db8486abc7ecb072
https://doi.org/10.1158/1535-7163.22504036
https://doi.org/10.1158/1535-7163.22504036
Autor:
Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, Urs B. Hagemann
Binding of CD33 antibody and CD33 antibody chelator-conjugate to CD33-positive HL-60 cells by FACS staining in comparison to an isotype control. Bound antibodies were detected using secondary PE-labeled anti-human antibody. Median fluorescence intens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86281a6228865dcc88f6a91470e14717
https://doi.org/10.1158/1535-7163.22504042
https://doi.org/10.1158/1535-7163.22504042
Autor:
Kristine Sponheim, Jenny Karlsson, Katrine Wickstroem, Ellen Wang, Adam O. Shea, Urs B. Hagemann, Alan Cuthbertson, Roger M. Bjerke, Olav B. Ryan
Publikováno v:
Molecular Cancer Therapeutics. 15:2422-2431
The clinical efficacy of the first approved alpha pharmaceutical, Xofigo (radium-223 dichloride, 223RaCl2), has stimulated significant interest in the development of new alpha-particle emitting drugs in oncology. Unlike radium-223 (223Ra), the parent